Top-News
Gesundheitswesen: Ausstattung u. Produkte USA

Boston Scientific News

Aktie
WKN:  884113 ISIN:  US1011371077 US-Symbol:  BSX
72,00 €
+0,00 €
0,00%
28.06.24
Handeln Depot/Watchlist
Aktienanzahl *
1,46 Mrd.
Marktkapitalisierung *
105,30 Mrd. €
Streubesitz
53,86%
Index-Zugehörigkeit
S&P 500
IR-Website
zur Website
*Stand: 14.12.2023
Weiter aufwärts? Long handeln - Jetzt mit Hebel 18,28: ME98V9
Werbung

Boston Scientific News

18.06.24 - PR Newswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc. PR Newswire
18.06.24 - PR Newswire
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc. PR Newswire
18.05.24 - PR Newswire
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints PR Newswire
08.05.24 - PR Newswire
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors PR Newswire
27.04.24 - Der Aktionär
Olivier Litzka von Andera Partners: "Über vier Milliarden Euro under Management"
24.04.24 - PR Newswire
Boston Scientific Announces Results for First Quarter 2024
Boston Scientific Announces Results for First Quarter 2024 PR Newswire
08.04.24 - PR Newswire
Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module
Boston Scientific Initiates NAVIGATE-​PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module PR Newswire
01.04.24 - PR Newswire
Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results
Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results PR Newswire
01.03.24 - PR Newswire
Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon
Boston Scientific Receives FDA Approval for the AGENT™ Drug-​Coated Balloon PR Newswire
27.02.24 - PR Newswire
Boston Scientific Announces Completion of €2.0 Billion Offering of Senior Notes
Boston Scientific Announces Completion of €2.0 Billion Offering of Senior Notes PR Newswire
22.02.24 - PR Newswire
Boston Scientific Announces Pricing of €2.0 Billion of Senior Notes
Boston Scientific Announces Pricing of €2.0 Billion of Senior Notes PR Newswire
05.02.24 - PR Newswire
Boston Scientific to Participate in TD Cowen's 44th Annual Health Care Conference
Boston Scientific to Participate in TD Cowen's 44th Annual Health Care Conference PR Newswire
31.01.24 - PR Newswire
Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 PR Newswire
31.01.24 - PR Newswire
Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System
Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System PR Newswire
31.01.24 - wallstreet:online Zentralredaktion
Ihre wichtigsten Termine: Zahlen von: Boeing, Mastercard, Novo Nordisk, Novartis und Qualcomm
Gut geplant in den Tag. Mit dem w:o-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
26.01.24 - PR Newswire
AXONICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
AXONICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ...
08.01.24 - PR Newswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc. PR Newswire
08.01.24 - PR Newswire
Boston Scientific Announces Agreement to Acquire Axonics, Inc.
Boston Scientific Announces Agreement to Acquire Axonics, Inc. PR Newswire
05.01.24 - PR Newswire
Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results PR Newswire
28.12.23 - PR Newswire
Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation
Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-​Line Treatment for Persistent Atrial Fibrillation PR Newswire

Newssuche

Videos

newspaper
27.06.24 -2,79%
Technical Trading: 10yr T-Notes Long Chance
10yr T-Notes Long Typ: Turbo Open End WKN: JL04UJ Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »